SCHEMBL3369368

SCHEMBL3369368

COc1ccc(S(=O)(=O)n2cc(C=O)cc2-c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 3/20 0.44
TUBB4A P04350 2/20 0.44
TUBB P07437 2/20 0.44
TUBA3C P0DPH7 2/20 0.44
TUBA1B P68363 2/20 0.44
TUBA4A P68366 2/20 0.44
TUBB4B P68371 2/20 0.44
TUBB3 Q13509 2/20 0.44
TUBB2A Q13885 2/20 0.44
TUBB8 Q3ZCM7 2/20 0.44
TUBA3E Q6PEY2 2/20 0.44
TUBA1A Q71U36 2/20 0.44
TUBA1C Q9BQE3 2/20 0.44
TUBB6 Q9BUF5 2/20 0.44
TUBB2B Q9BVA1 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3368043 0.91 TUBB4A (0.44) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1156459 0.84 ALDH1A1 (0.54) L3MBTL1PKMNPC1PKLRRAB9A
SCHEMBL3371555 0.83 CA12 (0.43) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25189206 0.82 PTGS2 (0.45) PKMNPC1PKLRRAB9AMAPT
SCHEMBL1156479 0.82 PTGS2 (0.45) PKMNPC1PKLRRAB9AMAPT
SCHEMBL5696178 0.81 RAPGEF4 (0.53) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5696246 0.81 L3MBTL1 (0.47) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25188871 0.80 ALDH1A1 (0.41) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL31019966 0.80 ALDH1A1 (0.41) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL25182337 0.77 PKM (0.44) L3MBTL1PKMNPC1PKLRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP disclosed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US disclosed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US disclosed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP disclosed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 TUBB1 2839/4885TUBB4A 3241/4885TUBB 3349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.